211 related articles for article (PubMed ID: 15207617)
1. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
2. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Vaccine; 2005 Feb; 23(14):1720-9. PubMed ID: 15705478
[TBL] [Abstract][Full Text] [Related]
3. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
Ritter U; Meissner A; Scheidig C; Körner H
Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
[TBL] [Abstract][Full Text] [Related]
4. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
5. Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine.
García-Piñeres AJ; Hildesheim A; Trivett M; Williams M; Wu L; Kewalramani VN; Pinto LA
Eur J Immunol; 2006 Feb; 36(2):437-45. PubMed ID: 16385626
[TBL] [Abstract][Full Text] [Related]
6. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
[TBL] [Abstract][Full Text] [Related]
7. Insights into Langerhans cell function from Langerhans cell ablation models.
Kaplan DH; Kissenpfennig A; Clausen BE
Eur J Immunol; 2008 Sep; 38(9):2369-76. PubMed ID: 18792030
[TBL] [Abstract][Full Text] [Related]
8. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
[TBL] [Abstract][Full Text] [Related]
9. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Cancer Res; 2003 Jul; 63(13):3478-82. PubMed ID: 12839929
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting.
Srinivas O; Larrieu P; Duverger E; Boccaccio C; Bousser MT; Monsigny M; Fonteneau JF; Jotereau F; Roche AC
Bioconjug Chem; 2007; 18(5):1547-54. PubMed ID: 17602511
[TBL] [Abstract][Full Text] [Related]
11. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
Lenz P; Lowy DR; Schiller JT
Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
[TBL] [Abstract][Full Text] [Related]
12. Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.
Rappocciolo G; Jais M; Piazza PA; DeLucia DC; Jenkins FJ; Rinaldo CR
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768873
[TBL] [Abstract][Full Text] [Related]
13. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors.
Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH
J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252
[TBL] [Abstract][Full Text] [Related]
14. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells.
Bousarghin L; Hubert P; Franzen E; Jacobs N; Boniver J; Delvenne P
J Gen Virol; 2005 May; 86(Pt 5):1297-1305. PubMed ID: 15831940
[TBL] [Abstract][Full Text] [Related]
16. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
[TBL] [Abstract][Full Text] [Related]
17. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
18. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
19. Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-beta.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Immunol Cell Biol; 2005 Feb; 83(1):83-91. PubMed ID: 15661045
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell receptors.
Ingber A
Dermatol Clin; 2007 Oct; 25(4):559-62, ix. PubMed ID: 17903614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
